David Engelberg

Dr. David Engelberg

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Trends in Biochemical Sciences
Verified
Journal Article
Closed access
JBJonah Beenstock
Jonah Beenstock
NMNavit Mooshayef
Navit Mooshayef
DEDavid Engelberg
David Engelberg

1 December 2014 in Cellular Signalling
Verified
Journal Article
Closed access
DEDavid Engelberg
David Engelberg
RPRiki Perlman
Riki Perlman
ALAlexander Levitzki
Alexander Levitzki

15 March 2016 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
KSKarina Smorodinsky-Atias
Karina Smorodinsky-Atias
TGTal Goshen-Lago
Tal Goshen-Lago
AGAnat Goldberg-Carp
Anat Goldberg-Carp
DMDganit Melamed
Dganit Melamed
ASAlexei Shir
Alexei Shir
DEDavid Engelberg
David Engelberg
The Receptor-Tyrosine Kinase(RTK)/Ras/Raf pathway is an essential cascade for mediating growth factor signaling. It is abnormally overactive in almost all human cancers. The downstream targets of the pathway are members of the Extracellular Regulated Kinases (Erk1/2) family, suggesting that this family is a mediator of the oncogenic capability of the cascade. Although all oncogenic mutations in the pathway result in strong activation of Erks, activating mutations in Erks themselves were not reported in cancers. Here we used spontaneously active Erk variants to check whether Erk's activity per se is sufficient for oncogenic transformation. We show that Erk1(R84S) is an oncoprotein as NIH3T3 cells that express it form foci in tissue culture plates, colonies in soft agar and tumors in nude mice. We further show that Erk1(R84S) and Erk2(R65S) are intrinsically active due to an unusual autophosphorylation activity they acquired. They autophosphorylate the activatory TEY motif, and also other residues, including the critical residue Thr207 (in Erk1)/Thr188 (in Erk2). Strikingly, Erk2(R65S) is efficiently autophosphorylating its Thr188 even when dually mutated in the TEY motif. Thus, this study shows that Erk1 can be considered a proto-oncogene and that Erk molecules possess unusual autoregulatory properties, some of them are independent of TEY phosphorylation.

6 January 2020 in Cells
Verified
Journal Article
Open access
PDF file
KSKarina Smorodinsky-Atias
Karina Smorodinsky-Atias
NSNadine Soudah
Nadine Soudah
DEDavid Engelberg
David Engelberg
Unique characteristics distinguish extracellular signal-regulated kinases (Erks) from other eukaryotic protein kinases (ePKs). Unlike most ePKs, Erks do not autoactivate and they manifest no basal activity; they become catalysts only when dually phosphorylated on neighboring Thr and Tyr residues and they possess unique structural motifs. Erks function as the sole targets of the receptor tyrosine kinases (RTKs)-Ras-Raf-MEK signaling cascade, which controls numerous physiological processes and is mutated in most cancers. Erks are therefore the executers of the pathway’s biology and pathology. As oncogenic mutations have not been identified in Erks themselves, combined with the tight regulation of their activity, Erks have been considered immune against mutations that would render them intrinsically active. Nevertheless, several such mutations have been generated on the basis of structure-function analysis, understanding of ePK evolution and, mostly, via genetic screens in lower eukaryotes. One of the mutations conferred oncogenic properties on Erk1. The number of interesting mutations in Erks has dramatically increased following the development of Erk-specific pharmacological inhibitors and identification of mutations that cause resistance to these compounds. Several mutations have been recently identified in cancer patients. Here we summarize the mutations identified in Erks so far, describe their properties and discuss their possible mechanism of action.

15 June 2015 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
CBChen Bai
Chen Bai
MTMasha Tesker
Masha Tesker
DEDavid Engelberg
David Engelberg
Transcription factors are commonly activated by signal transduction cascades and induce expression of many genes. They therefore play critical roles in determining the cell's fate. The yeast Hog1 MAP kinase pathway is believed to control the transcription of hundreds of genes via several transcription factors. To identify the bona fide target genes of Hog1, we inducibly expressed the spontaneously active variant Hog1D170A+F318Lin cells lacking the Hog1 activator Pbs2. This system allowed monitoring the effects of Hog1 by itself. Expression of Hog1D170A+F318Lin pbs2∆ cells imposed induction of just 105 and suppression of only 26 transcripts by at least twofold. We looked for the Hog1-responsive element within the promoter of the most highly induced gene, STL1 (88-fold). A novel Hog1 responsive element (HoRE) was identified and shown to be the direct target of the transcription factor Hot1. Unexpectedly, we could not find this HoRE in any other yeast promoter. In addition, the only gene whose expression was abolished in hot1∆ cells was STL1. Thus Hot1 is essential for transcription of just one gene, STL1. Hot1 may represent a class of transcription factors that are essential for transcription of a very few genes or even just one.

2 April 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
IDIlona Darlyuk-Saadon
Ilona Darlyuk-Saadon
CBChen Bai
Chen Bai
MHMatthew Heng
Matthew Heng
NGNechama Gilad
Nechama Gilad
WYWei-Ping Yu
Wei-Ping Yu
DEDavid Engelberg
David Engelberg
One third of the western population suffers from nonalcoholic fatty liver disease (NAFLD), which may ultimately develop into hepatocellular carcinoma (HCC). The molecular event(s) that triggers the disease are not clear. Current understanding, known as the multiple hits model, suggests that NAFLD is a result of diverse events at several tissues (e.g., liver, adipose tissues, and intestine) combined with changes in metabolism and microbiome. In contrast to this prevailing concept, we report that fatty liver could be triggered by a single mutated protein expressed only in the liver. We established a transgenic system that allows temporally controlled activation of the MAP kinase p38α in a tissue-specific manner by induced expression of intrinsically active p38α allele. Here we checked the effect of exclusive activation in the liver. Unexpectedly, induction of p38α alone was sufficient to cause macrovesicular fatty liver. Animals did not become overweight, showing that fatty liver can be imposed solely by a genetic modification in liver per se and can be separated from obesity. Active p38α-induced fatty liver is associated with up-regulation of MUC13, CIDEA, PPARγ, ATF3, and c-jun mRNAs, which are up-regulated in human HCC. Shutting off expression of the p38α mutant resulted in reversal of symptoms. The findings suggest that p38α plays a direct causative role in fatty liver diseases and perhaps in other chronic inflammatory diseases. As p38α activity was induced by point mutations, it could be considered a proto-inflammatory gene (proto-inflammagene). Significance While the MAPK p38α is highly active in nonalcoholic fatty liver disease (NAFLD), whether its constitutive activity is a driver or mere consequence of pathology remains unclear. This was not answered due to the lack of methods for specific p38α activation in vivo. A transgenic mouse model allowing inducible expression of an intrinsically active p38α variant in a tissue-specific manner meets this challenge. Upon expression of the active p38α allele in the liver, mice develop lipidosis (fatty liver) within four weeks without gaining overweight. This study shows that fatty liver could occur in response to activation of a single protein and provides the first genetic model for revealing the etiology of fatty liver diseases from the point of their trigger.